Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epoetin alfa for presurgical autologous blood donation in anemic patients
NCT00270062Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- May 1989
01
Overview
Phase 3, randomised, double-blind trial in anemia comparing Epoetin alfa with Placebo (2 arms). Primary endpoints: Number of units of blood self-donated at 3 weeks, Number of donor-donated units of blood used at 4 weeks and 3 more. Started May 1989; status: completed.
02
Drugs
epoetin alfa
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00270062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00270062.